目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH DATA SOURCES
2.2.1 SECONDARY RESEARCH SOURCES
2.2.2 PRIMARY RESEARCH SOURCES
2.2.2.1 Primary sources
2.2.2.2 Key industry insights
2.2.2.3 Breakdown of primaries
2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.3.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
2.3.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
2.4 MARKET FORECASTING APPROACH
2.4.1.1 CAGR projections
2.5 DATA TRIANGULATION APPROACH
2.6 STUDY ASSUMPTIONS
2.7 RISK ASSESSMENT
2.7.1 RISK ASSESSMENT: ORTHOPEDIC BRACES & SUPPORTS MARKET

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 ORTHOPEDIC BRACES & SUPPORTS MARKET OVERVIEW
4.2 REGIONAL SNAPSHOT OF ORTHOPEDIC BRACES & SUPPORTS MARKET

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rise in incidence of musculoskeletal and joint-related conditions
5.2.1.2 Growth in incidence of athletic and accident-induced musculoskeletal injuries
5.2.1.3 Increase in consciousness around preventive orthopedic health
5.2.2 RESTRAINTS
5.2.2.1 Low public awareness regarding available orthopedic treatment options
5.2.2.2 Reimbursement challenges in emerging and developed markets
5.2.3 OPPORTUNITIES
5.2.3.1 Expansion in pediatric and geriatric orthopedics
5.2.3.2 Shift toward at-home rehabilitation and remote patient monitoring
5.2.3.3 Rising demand for ready-to-use orthopedic supports via eCommerce platforms
5.2.4 CHALLENGES
5.2.4.1 Shortage of trained orthotists and technicians
5.2.4.2 Poor fitness and bulkiness of braces affect wearability and long-term usage
5.3 REGULATORY LANDSCAPE
5.3.1 KEY REGULATORY GUIDELINES
5.3.1.1 North America
5.3.1.2 Europe
5.3.1.2.1 UK
5.3.1.2.2 France
5.3.1.2.3 Germany
5.3.1.3 Asia Pacific
5.3.1.3.1 China
5.3.1.3.2 Japan
5.3.1.3.3 India
5.3.1.4 Latin America
5.3.1.4.1 Brazil
5.3.1.4.2 Mexico
5.3.1.5 Middle East & Africa
5.3.1.5.1 Saudi Arabia
5.3.1.5.2 United Arab Emirates (UAE)
5.3.1.5.3 South Africa
5.4 REIMBURSEMENT SCENARIO ANALYSIS
5.5 VALUE CHAIN ANALYSIS
5.5.1 R&D
5.5.2 RAW MATERIAL PROCUREMENT & PRODUCT DEVELOPMENT
5.5.3 MARKETING, SALES, AND DISTRIBUTION
5.5.4 POST-SALES SERVICES
5.6 SUPPLY CHAIN ANALYSIS
5.6.1 RAW MATERIAL
5.6.2 MANUFACTURING
5.6.3 SALES & DISTRIBUTIONS
5.6.4 END USERS
5.7 ECOSYSTEM MARKET MAP
5.8 TRADE ANALYSIS
5.8.1 IMPORT SCENARIO (HS CODE 902110)
5.8.2 EXPORT SCENARIO (HS CODE 902110)
5.9 PATENT ANALYSIS
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE TREND FOR ORTHOPEDIC BRACES
5.10.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS FOR ORTHOPEDIC BRACES
5.10.3 AVERAGE SELLING PRICE TREND OF ORTHOPEDIC BRACES, BY REGION
5.11 TECHNOLOGY ANALYSIS
5.11.1 KEY TECHNOLOGIES
5.11.1.1 Advanced material technologies
5.11.2 COMPLEMENTARY TECHNOLOGIES
5.11.2.1 Mobile health (M-health) & tele-rehabilitation platforms
5.11.3 ADJACENT TECHNOLOGIES
5.11.3.1 Prosthetics and orthotics technologies
5.12 PORTER'S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 KEY BUYING CRITERIA
5.14 KEY CONFERENCES & EVENTS
5.15 CASE STUDY ANALYSIS
5.15.1 RAPID BRACING INTERVENTION ENABLES ACTIVE LIFESTYLE DESPITE KNEE INJURY: SAMANTHA'S JOURNEY WITH ARTHRITIS & INJURY CARE CENTRE
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.17 INVESTMENT & FUNDING SCENARIO
5.18 UNMET NEEDS
5.19 IMPACT OF AI ON ORTHOPEDIC BRACES & SUPPORTS MARKET
5.19.1 INTRODUCTION
5.19.2 MARKET POTENTIAL OF AI ON ORTHOPEDIC BRACES & SUPPORTS
5.19.3 AI USE CASES
5.19.4 KEY COMPANIES IMPLEMENTING AI
5.19.5 FUTURE OF AI ON ORTHOPEDIC BRACES & SUPPORTS MARKET
5.20 IMPACT OF 2025 US TARIFF - ORTHOPEDIC BRACES & SUPPORTS MARKET
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 IMPACT ON COUNTRY/REGION
5.20.4.1 US
5.20.4.2 Europe
5.20.4.3 Asia Pacific
5.20.5 IMPACT ON END-USE INDUSTRIES

6 ORTHOPEDIC BRACES & SUPPORTS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 KNEE BRACES & SUPPORTS
6.2.1 GROWTH IN ELDERLY POPULATION COUPLED WITH SURGE IN SPORTS-RELATED INJURIES
6.3 ANKLE BRACES & SUPPORTS
6.3.1 INCREASE IN INCIDENCE OF ANKLE INJURIES AND ANKLE OSTEOARTHRITIS
6.4 FOOT WALKER & ORTHOSES
6.4.1 RISE IN INCIDENCE OF DIABETES AND AWARENESS ABOUT PREVENTIVE FOOT CARE
6.5 BACK, HIP, AND SPINE BRACES & SUPPORTS
6.5.1 INCREASE IN INCIDENCE OF LOWER BACK PAIN, SPINAL STENOSIS, SCOLIOSIS, HERNIATED DISCS, AND DEGENERATIVE DISC DISEASES
6.5.2 NECK AND CERVICAL BRACES & SUPPORTS
6.5.2.1 Increase in incidence of neck injuries caused by road accidents, sports-related incidents, and occupational hazards
6.5.3 LOWER SPINE BRACES & SUPPORTS
6.5.3.1 Growth in aging population prone to lower spine degeneration
6.6 SHOULDER BRACES & SUPPORTS
6.6.1 RISE IN CASES OF SPORTS INJURIES, ROAD ACCIDENTS, AND AGE-RELATED MUSCULOSKELETAL DISORDERS
6.7 ELBOW BRACES & SUPPORTS
6.7.1 GROWTH IN PARTICIPATION IN PHYSICAL AND ATHLETIC ACTIVITIES, COUPLED WITH GREATER AWARENESS OF NON-INVASIVE ORTHOPEDIC TREATMENTS AND EARLY INTERVENTION
6.8 HAND & WRIST BRACES & SUPPORTS
6.8.1 AGING POPULATION AND REPETITIVE STRAIN INJURIES AMONG WORKERS
6.9 FACIAL BRACES & SUPPORTS
6.9.1 INCREASE IN DEMAND FOR FACIAL RECONSTRUCTION SURGERIES AND RISE IN INCIDENCE OF CONGENITAL CRANIAL DEFORMITIES

7 ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE
7.1 INTRODUCTION
7.2 SOFT AND ELASTIC BRACES & SUPPORTS
7.2.1 ADVANTAGES OF SOFT & ELASTIC BRACES AND SUPPORTS INCLUDE THEIR FLEXIBILITY AND EASE OF USE
7.3 HARD BRACES & SUPPORTS
7.3.1 SUPPORTIVE REIMBURSEMENT SCENARIO AND RISING PREVALENCE OF TARGET DISEASES
7.4 HINGED BRACES & SUPPORTS
7.4.1 GROWTH IN GERIATRIC POPULATION AND RISE IN INCIDENCE OF LIGAMENT INJURIES

8 ORTHOPEDIC BRACES & SUPPORTS MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 PREVENTIVE CARE
8.2.1 INCREASE IN PUBLIC PARTICIPATION IN SPORTS-RELATED ACTIVITIES
8.3 LIGAMENT INJURY
8.3.1 ANTERIOR CRUCIATE LIGAMENT (ACL) INJURY
8.3.1.1 ACL injury applications to register highest growth rate during forecast period
8.3.2 LATERAL COLLATERAL LIGAMENT (LCL) INJURY
8.3.2.1 Rise in reimbursements of LCL-related surgical procedures
8.3.3 OTHER LIGAMENT INJURY
8.4 POST-OPERATIVE REHABILITATION
8.4.1 INCREASE IN NUMBER OF ORTHOPEDIC RECONSTRUCTIVE SURGERIES
8.5 OSTEOARTHRITIS
8.5.1 RISE IN OSTEOARTHRITIS CASES AND PUBLIC AWARENESS ON SIDE-EFFECTS OF ORAL MEDICATION FOR PAIN MANAGEMENT
8.6 COMPRESSION THERAPY
8.6.1 INNOVATION OF TECHNOLOGICALLY ADVANCED COMPRESSION BRACES
8.7 FRACTURE MANAGEMENT
8.7.1 RISE IN FRACTURE INCIDENCE, AGING POPULATIONS WITH OSTEOPOROSIS, AND GROWING PREFERENCE FOR NON-SURGICAL, EARLY MOBILIZATION SOLUTIONS
8.8 OTHER APPLICATIONS

9 ORTHOPEDIC BRACES & SUPPORTS MARKET, BY DISTRIBUTION CHANNEL
9.1 INTRODUCTION
9.2 HOSPITALS & SURGICAL CENTERS
9.2.1 INCREASE IN INVESTMENTS IN HOSPITAL INFRASTRUCTURE
9.3 ORTHOPEDIC CLINICS
9.3.1 SHORTER HOSPITAL STAYS, REDUCED TREATMENT COSTS, AND IMPROVED POST-OPERATIVE CARE
9.4 PHARMACIES & RETAILERS
9.4.1 WIDESPREAD AVAILABILITY OF PRODUCTS THROUGH RETAIL STORES AND PHARMACIES
9.5 E-COMMERCE PLATFORMS
9.5.1 GROWTH IN POPULARITY OF ECOMMERCE AND ITS CONVENIENCE
9.6 DME DEALERS
9.6.1 GROWTH IN ELDERLY POPULATION AND RISE IN INCIDENCE OF CHRONIC HEALTH CONDITIONS
9.7 OTHER DISTRIBUTION CHANNELS

10 ORTHOPEDIC BRACES & SUPPORTS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
10.2.2 US
10.2.2.1 Rise in cases of osteoarthritis and rheumatoid arthritis and growth in preference for minimally invasive procedures
10.2.3 CANADA
10.2.3.1 Increase in prevalence of degenerative bone disorders and uptick in road accident-related injuries
10.3 EUROPE
10.3.1 EUROPE: MACROECONOMIC OUTLOOK
10.3.2 GERMANY
10.3.2.1 Rise in engagement in sports activities and growing awareness of healthy living
10.3.3 UK
10.3.3.1 Rise in awareness of orthopedic health issues challenged by rising costs of procedures
10.3.4 FRANCE
10.3.4.1 Increase in incidence of musculoskeletal disorders
10.3.5 ITALY
10.3.5.1 High incidence of sports-related injuries often managed non-invasively
10.3.6 SPAIN
10.3.6.1 Increase in presence of leading manufacturers and surge in osteoarthritis and osteoporosis cases
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
10.4.2 CHINA
10.4.2.1 Need for effective rehabilitation solutions and related products with expanding target patient population
10.4.3 JAPAN
10.4.3.1 Rapidly aging population and supportive government initiatives
10.4.4 INDIA
10.4.4.1 Shift from traditional analog systems to modern digital systems utilizing flat panel detectors (FPDs)
10.4.5 AUSTRALIA
10.4.5.1 Expanding patient base, advancements in product design, and ongoing efforts to improve musculoskeletal care
10.4.6 SOUTH KOREA
10.4.6.1 Hub for technological innovation in medical devices, with domestic companies investing in smart, wearable technologies
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
10.5.2 BRAZIL
10.5.2.1 Strong global player presence supported by extensive distribution networks
10.5.3 MEXICO
10.5.3.1 Improved access to healthcare services and increasing availability of ecommerce platforms
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
10.6.2 GCC COUNTRIES
10.6.2.1 Focus on infrastructure development and improved healthcare accessibility
10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.3 REVENUE ANALYSIS, 2022-2024
11.4 MARKET SHARE ANALYSIS, 2024
11.5 MARKET RANKING ANALYSIS, 2024
11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.6.5.1 Company footprint
11.6.5.2 Product footprint
11.6.5.3 Regional footprint
11.6.5.4 Type footprint
11.6.5.5 Application footprint
11.6.5.6 Distribution channel footprint
11.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.7.1 PROGRESSIVE COMPANIES
11.7.2 RESPONSIVE COMPANIES
11.7.3 DYNAMIC COMPANIES
11.7.4 STARTING BLOCKS
11.7.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024
11.7.5.1 Detailed list of key startups/SMEs
11.7.5.2 Competitive benchmarking of key startups/SMEs
11.8 COMPETITIVE SCENARIO
11.8.1 PRODUCT LAUNCHES AND APPROVALS
11.8.2 DEALS
11.9 COMPANY VALUATION & FINANCIAL METRICS
11.10 BRAND/PRODUCT COMPARISON

12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 3M COMPANY
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 MnM view
12.1.1.3.1 Key strengths/Right to win
12.1.1.3.2 Strategic choices
12.1.1.3.3 Weaknesses and competitive threats
12.1.2 ESSITY HEALTH & MEDICAL
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Deals
12.1.2.4 MnM view
12.1.2.4.1 Key strengths/Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 OSSUR
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product launches and approvals
12.1.3.3.2 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths/Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 THUASNE
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Deals
12.1.4.4 MnM view
12.1.4.4.1 Key strengths/Right to win
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 ZIMMER BIOMET HOLDINGS, INC.
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent development
12.1.5.3.1 Deals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths/Right to win
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 BIRD & CRONIN, LLC (DYNATRONICS CORPORATION)
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.7 ENOVIS CORPORATION
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.8 OTTOBOCK
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.9 BAUERFEIND
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.10 BREG, INC
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.11 DEROYAL INDUSTRIES, INC.
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.12 ALCARE CO., LTD
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.13 NIPPON SIGMAX CO., LTD.
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.14 MEDI GMBH & CO. KG
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.15 TRULIFE
12.1.15.1 Business overview
12.1.15.2 Products offered
12.2 OTHER PLAYERS
12.2.1 FOUNDATION WELLNESS (FORMERLY KNOWN AS REMINGTON PRODUCTS COMPANY)
12.2.2 MCDAVID, INC. (A PART OF SHOCK DOCTOR)
12.2.3 MUELLER SPORTS MEDICINE, INC.
12.2.4 BECKER ORTHOPEDIC
12.2.5 ORLIMAN S.L.U (A PART OF MAGNUM INDUSTRIAL PARTNERS)
12.2.6 FRANK STUBBS COMPANY INC.
12.2.7 ASPEN MEDICAL PRODUCTS LLC
12.2.8 DARCO INTERNATIONAL, INC.
12.2.9 UNITED MEDICARE
12.2.10 VISSCO REHABILITATION AIDS PVT. LTD.

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS